Removal of terminal α-galactosyl residues from xenogeneic porcine endothelial cells: Decrease in complement-mediated cytotoxicity but persistence of IgG1-mediated antibody-dependent cell-mediated cytotoxicity

Transplantation

Volumn 62, Issue 1, 1996, Pages 105-113

  Watier, Hervé ^a   Guillaumin, Jean Maurice ^a   Piller, Friedrich ^b   Lacord, Michèle ^a   Thibault, Gilles ^a   Lebranchu, Yvon ^a   Monsigny, Michel ^b   Bardos, Pierre ^a  

^a UNIVERSITÉ DE TOURS   (France)

^b CENTRE DE BIOPHYSIQUE MOLÉCULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSIDASE; CD16 ANTIGEN; GALACTOSE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN M; IMMUNOGLOBULIN SUBCLASS;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIGEN BINDING; ARTICLE; BINDING SITE; CARBOHYDRATE ANALYSIS; CYTOTOXICITY; ENDOTHELIUM CELL; GRAFT REJECTION; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SWINE; XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; COMPLEMENT SYSTEM PROTEINS; CYTOTOXICITY, IMMUNOLOGIC; ENDOTHELIUM, VASCULAR; EPITOPE MAPPING; GALACTOSIDASES; GALACTOSIDES; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MICE; STRUCTURE-ACTIVITY RELATIONSHIP; SWINE;

EID: 0029996878     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199607150-00020     Document Type: Article

References (60)

1. McKenzie IFC, Stocker J, Ting A, Morris PJ. Human lymphocytotoxic and hemagglutinating activity against sheep and pig cells. Lancet 1968; 2: 386.
2. Hammer C. Isohemagglutinins and preformed natural antibodies in xenogeneic organ transplantation. Transplant Proc 1987; 19: 4443.
3. Auchincloss H. Xenogeneic transplantation [Review]. Transplantation 1988; 46: 1.
4. Platt JL, Bach FH. The barrier to xenotransplantation. Transplantation 1991; 52: 937.
5. Galili U. Interaction of the natural anti-Gal antibody with alpha-galactosyl epitopes: a major obstacle for xenotransplantation in humans. Immunol Today 1993; 14: 480.
6. Cooper DKC, Koren E, Oriol R. Oligosaccharides and discordant xenotransplantation. Immunol Rev 1994; 141: 31.
7. Sandrin MS, Vaughan HA, McKenzie IFC. Identification of Gal(α1,3)Gal as the major epitope for pig-to-human vascularized xenografts. Transplant Rev 1994; 8: 134.
8. Samuelsson BE, Rydberg L, Breimer ME, et al. Natural antibodies and human xenotransplantation. Immunol Rev 1994; 141: 151.
9. Cooper DKC, Good AH, Koren E, et al. Identification of α-galactosyl and other carbohydrates that are bound by human antipig antibodies: relevance to discordant xenografting in man. Transplant Immunol 1993; 1: 198.
10. Neethling FA, Koren E, Ye Y, et al. Protection of pig kidney (PK15) cells from the cytotoxic effect of anti-pig antibodies by α-galactosyl oligosaccharides. Transplantation 1994; 57: 959.
11. Vaughan HA, Loveland BE, Sandrin MS. Gal α(1,3)Gal is the major xenoepitope expressed on pig endothelial, cells recognized by naturally occurring cytotoxic human antibodies. Transplantation 1994; 58: 879.
12. Thibaudeau K, Anegon I, Lemauff B, Soulillou JP, Blanchard D. Human natural antibodies to porcine platelets. Transplantation 1994; 57: 1110.
13. Goldberg L, Lee J, Cairns T, et al. Inhibition of the human antipig xenograft reaction with soluble oligosaccharides. Transplant Proc 1995; 27: 249.
14. Holzknecht ZE, Platt JL. Identification of porcine endothelial cell membrane antigens recognized by human xenoreactive natural antibodies. J Immunol 1995; 154: 4565.
15. Rieben R, von Allmen E, Korchagina EY, et al. Detection, immunoabsorption, and inhibition of cytotoxic activity of anti-αGal antibodies using newly developed substances with synthetic Galα-3Gal disaccharide epitopes. Xenotransplantation 1995; 2: 98.
16. Sandrin MS, Vaughan HA, Dabkowski PL, Mckenzie IFC. Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes. Proc Natl Acad Sci USA 1993; 90: 11391.
17. Oriol R, Ye Y, Koren E, Cooper DKC. Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation. Transplantation 1993; 56: 1433.
18. Cairns T, Hammelmann W, Gray D, Welsh K, Larson G. Enzymatic removal from various tissues of the galactose-α1,3-galactose target antigens of human anti-species antibodies. Transplant Proc 1994; 26: 1279.
19. Collins BH, Parker W, Platt JL. Characterization of porcine endothelial cell determinants recognized by human natural antibodies. Xenotransplantation 1994; 1: 36.
20. Parker W, Bruno D, Holzknecht ZE, Platt JL. Characterization and affinity isolation of xenoreactive human natural antibodies. J Immunol 1994; 153: 3791.
21. Zhao ZX, Termignon JL, Cardoso J, et al. Hyperacute xenograft rejection in the swine-to-human donor-recipient combination: in vitro analysis of complement activation. Transplantation 1994; 57: 245.
22. Vanhove B, de Martin R, Lipp J, Bach FH. Human xenoreactive natural antibodies of the IgM isotype activate pig endothelial cells. Xenotransplantation 1994; 1: 17.
23. Tuso PJ, Cramer DV, Yasunaga C, Cosenza CA, Wu GD, Makowka L. Removal of natural human xenoantibodies to pig vascular endothelium by perfusion of blood through pig kidneys and livers. Transplantation 1993; 55: 1375.
24. Borche L, Thibaudeau K, Navenot J-M, Soulillou J-P, Blanchard D. Cytolytic effect of human anti-Gal IgM and complement on porcine endothelial cells: a kinetic analysis. Xenotransplantation 1994; 1: 125.
25. Koren E, Kujundzic M, Koscec M, et al. Cytotoxic effects of human preformed anti-GAL IgG and complement on cultured pig cells. Transplant Proc 1994; 26: 1336.
26. Saadi S, Platt JL. Transient perturbation of endothelial integrity induced by natural antibodies and complement. J Exp Med 1995; 181: 21.
27. Platt JL, Lindman BJ, Geller RL, et al. The role of natural antibodies in the activation of xenogenic endothelial cells. Transplantation 1991; 52: 1037.
28. Kujundzic M, Koren E, Neethling FA, Milotic F, Koscec M, Kujundzic T. Variability of anti-αGal antibodies in human serum and their relation to serum cytotoxicity against pig cells. Xenotransplantation 1994; 1: 58.
29. Schaapherder AFM, Daha MR, Tebulte MTJW, Vanderwoude FJ, Gooszen HG. Antibody-dependent cell-mediated cytotoxicity against porcine endothelium induced by a majority of human sera. Transplantation 1994; 57: 1376.
30. Inverardi L, Pardi R. Early events in cell-mediated recognition of vascularized xenografts: cooperative interactions between selected lymphocyte subsets and natural antibodies. Immunol Rev 1994; 141: 71.
31. Ravetch JV, Kinet J-P. Fc receptors. Annu Rev Immunol 1991; 9: 457.
32. Michaelsen TE, Aase A, Norderhaug L, Sandlie I. Antibody dependent cell-mediated cytotoxicity induced by chimeric mouse-human IgG subclasses and IgG3 antibodies with altered hinge region. Mol Immunol 1992; 29: 319.
33. Sarmay G, Lund J, Rozsnyay Z, Gergely J, Jefferis R. Mapping and comparison of the interaction sites on the Fc region of IgG responsible for triggering antibody dependent cellular cytotoxicity (ADCC) through different types of human Fc receptor. Mol Immunol 1992; 29: 633.
34. Vance BA, Huizinga TWJ, Wardwell K, Guyre PM. Binding of monomeric human IgG defines an expression polymorphism of FcγRIII on large granular lymphocyte/natural killer cells. J Immunol 1993; 151: 6429.
35. Ross JR, Kirk AD, Ibrahim SE, Howell DN, Baldwin WM, Sanfilippo FP. Characterization of human anti-porcine natural antibodies recovered from ex vivo perfused hearts: predominance of IgM and IgG2. Transplantation 1993; 55: 1144.
36. Hammarström L, Smith CIE. IgG subclasses in bacterial infections. Monogr Allergy 1986; 19: 122.
37. Watier H, Vallée I, Thibault G, et al. Effect of human inflammatory cytokines on porcine endothelial cell MHC molecule expression: unique role for TNF-alpha in MHC class-II induction. Transplant Proc 1994; 26: 1152.
38. Galéa P, Thibault G, Lacord M, Bardos P, Lebranchu Y. IL-4, but not tumor necrosis factor-α, increases endothelial cell adhesiveness for lymphocytes by activating a cAMP-dependent pathway. J Immunol 1993; 151: 588.
39. Vallée I, Watier H, Thibault G, et al. Evidence of noninvolvement of swine MHC class II in the in vitro proliferative response of human lymphocytes to porcine endothelial cells. Transplantation 1995; 59: 897.
40. Pescovitz M, Lunney J, Sachs D. Preparation and characterization of monoclonal antibodies reactive with porcine PBL. J Immunol 1984; 133: 368.
41. Young WW, Portoukalian J, Hakomori S-I. Two monoclonal anticarbohydrate antibodies directed to glycosphingolipids with a lacto-N-glycosyl type II chain. J Biol Chem 1981; 256: 10967.
42. Jefferis R, Reimer C, Skvaril F, et al. Evaluation of monoclonal antibodies having specificity for human IgG subclasses: results of an WHO/IUIS collaborative study. Immunol Lett 1985; 10: 223.
43. Jefferis R, Reimer CB, Skvaril F, et al. Evaluation of monoclonal antibodies having specificity for human IgG subclasses: results of the second IUIS/WHO collaborative study. Immunol Lett 1992; 31: 143.
44. Aucouturier P, Lacombe C, Preud'homme JL. Serum IgG subclass level determination: methodological difficulties and practical aspects. Ann Biol Clin 1994; 52: 53.
45. Goldstein IJ, Blake DA, Ebisu S, Williams TJ, Murphy LA. Carbohydrate binding studies on the Bandeiraea simplicifolia I isolectins. J Biol Chem 1981; 256: 3890.
46. Monsigny M, Roche A-C, Sene C, Maget-Dana R, Delmotte F. Sugar-lectin interactions: how does wheat-germ agglutinin bind sialoglycoconjugates? Eur J Biochem 1980; 104: 147.
47. Shibuya N, Goldstein IJ, Broekaert WF, Nsimba-Lubaki M, Peeters B, Peumans WJ. The elderberry (Sambucus nigra L.) bark lectin recognizes the Neu5Ac(α2-6)Gal/GalNAc sequence. J Biol Chem 1987; 262: 1596.
48. DeBoeck H, Loontiens FG, Lis H, Sharon N. Binding of simple carbohydrates and some N-acetyllactosamine-containing oligosaccharides to Erythrina cristagalli agglutinin as followed with a fluorescent indicator ligand. Arch Biochem Biophys 1984; 234: 297.
49. Sarmay G, Jefferis R, Klein E, Benczur M, Gergely J. Mapping the functional topography of Fc with monoclonal antibodies: localization of epitopes interacting with the binding site of Fc receptor on human K cells. Eur J Immunol 1985; 15: 1037.
50. Greenwood J, Clark M, Waldmann H. Structural motifs involved in human IgG antibody effector functions. Eur J Immunol 1993; 23: 1098.
51. Westphal JR, Boerbooms AMT, Schalkwijk CJM, et al. Antiendothelial cell antibodies in sera of patients with autoimmune diseases: comparison between ELISA and FACS analysis. Clin Exp Immunol 1994; 96: 444.
52. Holgersson J, Cairns TDH, Karlsson EC, et al. Carbohydrate, specificity of human immunoglobulin-M antibodies with pig lymphocytotoxic activity. Transplant Proc 1992; 24: 605.
53. Vaughan HA, Mckenzie IFC, Sandrin MS. Biochemical studies of pig xenoantigens detected by naturally occurring human antibodies and the galactose α(1-3)galactose reactive lectin. Transplantation 1995; 59: 102.
54. Turman MA, Casali P, Notkins AL, Bach FH, Platt JL. Polyreactivity and antigen specificity of human xenoreactive monoclonal and serum natural antibodies. Transplantation 1991; 52: 710.
55. Möller E, Möller G. Quantitative studies of the sensitivity of normal and neoplastic cells to the cytotoxic action of isoantibodies. J Exp Med 1962; 115: 527.
56. Ye Y, Neethling FA, Niekrasz M, et al. Intravenous administration of α-galactosyl carbohydrates reduces in vivo baboon serum cytotoxicity to pig kidney cells and transplanted pig hearts. Transplant Proc 1994; 26: 1399.
57. McCoy JP, Chambers WJ. Carbohydrates in the function of natural killer cells. Glycobiology 1991; 1: 321.
58. Bezouska K, Yuen CT, O'Brien J, et al. Oligosaccharide ligands for NKR-P1 protein activate NK cells and cytotoxicity. Nature 1994; 372: 150.
59. Koene HR, de Haas M, Kleijer M, et al. Identification of a triallelic polymorphism on Fc[gamma]RIIIA [Abstract 2875]. Presented at the 9th International Congress of Immunology, San Francisco, 1995.
60. Ravindran B, Satapathy AK, Das MK. Naturally occurring anti-α galactosyl antibodies in human Plasmodium falciparum infections. A possible role for autoantibodies in malaria. Immunol Lett 1988; 19: 137.